cd19.car-cd28z t cells
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00586391)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cd19car-28-zeta t cells
- cd19.car-cd28z t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04850560 | Phase 1 | May 18, 2021 | Zhejiang University |
| NCT02050347 | Phase 1 | Apr 1, 2014 | Baylor University, Methodist Cancer Center, Houston, Texas |
| NCT00586391 | Phase 1 | Feb 1, 2009 | Baylor University, Methodist Cancer Center, Houston, Texas |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 2 | 2 | 1 | 2009 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 2 | 0 | 1 | 2009 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1